Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Exagen Inc. buy BiotechBee

Exagen Inc.
Start price
€6.00
02.12.23 / 50%
Target price
€2.60
31.12.25
Performance (%)
-
End price
-
04.12.23
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Exagen Inc. - - -
iShares Core DAX® 0.734% 1.458% 17.980%
iShares Nasdaq 100 -2.686% -0.146% 3.810%
iShares Nikkei 225® -2.261% -2.729% 11.679%
iShares S&P 500 -1.346% 0.467% 1.970%

According to BiotechBee what are the pros and cons of Exagen Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Exagen Inc. diskutieren
Prediction Buy
Perf. (%) -
Target price 2.600
Change
Ends at 31.12.25

Buy mit Kursziel 2,6

BiotechBee 
0
Report Share
02.12.23
In the thread Trading Exagen Inc.
Prediction Buy
Perf. (%) -
Target price 2.600
Change
Ends at 31.12.25

Buy beendet

BiotechBee 
0
Report Share
04.12.23

Stopped prediction by BiotechBee for Exagen Inc.

buy
Exagen Inc.

Start price
Target price
Perf. (%)
€2.80
08.09.24
€3.70
31.05.27
96.43%
14.12.24

Could be very worthwhile Investment >20% year
BiotechBee 
08.09.24 50%